TABLE 4.
Target organ | Absorbed dose (cGy) per 2,220 MBq of administered activity | ||
---|---|---|---|
Current study | CardioGen-82 PI | ICRP 53 | |
Adrenals | 4.65E−01 | 2.20E−01 | 4.44E+00 |
Brain | 3.81E−02 | NA | NA |
Breasts | 5.17E−02 | NA | 4.22E−02 |
Gallbladder wall | 1.85E−01 | NA | NA |
LLI wall | 1.54E−01 | 1.90E−01 | 8.66E−01 |
SI | 2.87E−01 | 3.20E−01 | 8.66E−01 |
Stomach wall | 4.88E−01 | 1.90E−01 | 8.44E−01 |
ULI wall | 3.09E−01 | 1.90E−01 | 8.66E−01 |
Heart wall | 8.56E−01 | 4.20E−01 | 7.33E−01 |
Kidneys | 1.29E+00 | 1.92E+00 | 4.00E+00 |
Liver | 2.42E−01 | 1.90E−01 | 2.15E−01 |
Lungs | 6.57E−01 | 3.80E−01 | 5.33E−01 |
Muscle | 7.71E−02 | NA | NA |
Ovaries | 8.12E−02 | 8.40E−02 | 5.33E−02 |
Pancreas | 5.23E−01 | 1.40E−01 | 9.99E−01 |
Red marrow | 6.94E−02 | 8.40E−02 | 2.20E−01 |
Osteogenic cells | 1.10E−01 | NA | 1.49E−01 |
Skin | 6.82E−02 | NA | NA |
Spleen | 4.25E−01 | NA | 1.11E+00 |
Testes | 4.06E−02 | 6.6E−02 | 2.89E−02 |
Thymus | 8.82E−02 | NA | NA |
Thyroid | 3.98E−01 | NA | 8.44E+00 |
Urinary bladder wall | 9.49E−02 | NA | 3.77E−02 |
Uterus | 2.20E−01 | NA | 4.66E−02 |
Total body | 1.06E−01 | 9.60E−02 | NA |
NA = not available.